Insmed | Passività Correnti



Current Liabilities Cambiamento Data
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Cytokinetics USD 131.06M 28.66M 2025-06
DBV Technologies USD 40.38M 9.25M 2025-03
Dynavax Technologies USD 118.23M 49.85M 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
Insmed USD 311.68M 72.45M 2025-06
Novartis USD 28.69B 560M 2024-12
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06


Insmed Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.